| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab. | Arch Neurol | 2011 | 2.75 |
| 2 | Phase II, randomized, multicenter, comparative study of peginterferon-alpha-2a (40 kD) (Pegasys) versus interferon alpha-2a (Roferon-A) in patients with treatment-naïve, chronic-phase chronic myelogenous leukemia. | Leuk Lymphoma | 2007 | 1.51 |
| 3 | Randomized dose-escalation study evaluating peginterferon alfa-2a in patients with metastatic malignant melanoma. | J Clin Oncol | 2006 | 0.95 |